Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

1201

Full text

1010

Free full text

602

Publication Types

Journal Article

1216

Research Support, Non-U.S. Gov't

475

Randomized Controlled Trial

415

Review

307

Multicenter Study

267

Clinical Trial, Phase II

218

Comparative Study

138

Clinical Trial, Phase III

128

Research Support, N.I.H., Extramural

98

Systematic Review

82

Meta-Analysis

75

Clinical Trial

74

Observational Study

72

Clinical Trial, Phase I

49

Case Reports

26

Network Meta-Analysis

17

Letter

10

Comment

9

Editorial

8

Research Support, N.I.H., Intramural

7

Clinical Trial Protocol

5

Controlled Clinical Trial

5

Research Support, U.S. Gov't, Non-P.H.S.

4

Research Support, U.S. Gov't, P.H.S.

4

Clinical Trial, Phase IV

4

Validation Study

2

Consensus Development Conference

2

Practice Guideline

2

Equivalence Trial

2

Evaluation Study

1

Retracted Publication

1

Video-Audio Media

1

Pragmatic Clinical Trial

1

Publication Year

From

To

Quick links

Individual year

2026

9

2025

41

2024

48

2023

56

2022

81

2021

90

2020

74

2019

74

2018

52

2017

88

2016

78

2015

72

2014

63

2013

60

2012

77

2011

51

2010

48

2009

58

2008

48

2007

32

2006

21

2005

11

2004

6

2003

4

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Bevacizumab""[mesh_terms]

1242 Results

Searching titles within these results

Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?

Leonardo Gomes da Fonseca, Federico Piñero

World journal of gastroenterology 2021;27(24):3429-3439

Systemic therapies in hepatocellular carcinoma: A revolution?

Marco Sanduzzi-Zamparelli, Maria Reig, Marta Fortuny

United European gastroenterology journal 2024;12(2):252-260

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review.

Richard S Finn, Virginia Corbett, Sarah Cappuyns, Josep M Llovet, Mark Yarchoan

JAMA oncology 2024;10(3):395-404

Efficacy and safety of phacoemulsification cataract surgery with prophylactic vitreous injection of bevacizumab in the treatment of retinopathy: a systematic review and meta-analysis.

Lei Du, Zhongshan Chen, Lan Wu

Annals of palliative medicine 2022;11(4):1421-1430

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective.

Qiang Gao, Jia Fan, Jian Zhou, Jieyi Shi, Diyang Xie

Clinical and molecular hepatology 2023;29(2):206-216

Combination immunotherapy for hepatocellular carcinoma.

Bruno Sangro, Richard S Finn, Lorenza Rimassa

Journal of hepatology 2023;79(2):506-515

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review.

Virginia Corbett, Sarah Cappuyns, Josep M Llovet, Mark Yarchoan, Richard S Finn

JAMA oncology 2024;10(3):395-404

Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.

Ayush Kaushal, Abdul Kareem Pullattayil, Waseemoddin Patel, Abdul Razak, Monika Kaushal

Journal of perinatology : official journal of the California Perinatal Association 2021;41(6):1225-1235

Evolving therapeutic landscape of advanced hepatocellular carcinoma.

Chen Yang, Cun Wang, Wenxin Qin, René Bernards, Andrew X Zhu, Hailin Zhang, Linmeng Zhang

Nature reviews. Gastroenterology & hepatology 2023;20(4):203-222

TKIs in combination with immunotherapy for hepatocellular carcinoma.

Rusi Chen, Luca Ielasi, Bernardo Stefanini, Chiara Abbati, Alessandro Granito, Francesco Tovoli, Matteo Tonnini

Expert review of anticancer therapy 2023;23(3):279-291

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis.

Hongfei Hu, Wenxi Tang, Zhaoshi Bai, Jifu Wei, Yue Yin, Xingming Pan, Mingye Zhao

Frontiers in public health 2022;10():869960

Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.

Maria Kristina Parr, Wolfgang Jabs, Volker Sandig, Karsten Winkler, Daniel Rehm, Yan Felix Karl Dyck

Journal of pharmaceutical and biomedical analysis 2023;235():115596

Systemic treatment for unresectable hepatocellular carcinoma.

PathompThep Leowattana, Tawithep Leowattana, Wattana Leowattana

World journal of gastroenterology 2023;29(10):1551-1568

The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma - A systematic review.

Howard J Lim, Vincent C Tam, Ravi Ramjeesingh, Deanna McLeod, David M Liu, Jennifer J Knox, Brandon M Meyers

Cancer treatment reviews 2023;118():102584

A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.

Peter Gibbs, Peter Nygren, Derek J Jonker, Gerald W Prager, Christos Papadimitriou, Heinz-Josef Lenz, Takayuki Yoshino, Sebastian Stintzing, Roger Tell, Aimery de Gramont, Josep Tabernero

Cancer research communications 2024;4(1):28-37

Results: 1 – 15 / 1242

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.